Search

everythinglearnresearchcommunity

for

Search:↓

Skin disease activity scores can help decide when skin symptoms no longer affect the quality of life in patients with mild dermatomyositis.

Most men stopped using finasteride for baldness due to unsatisfactory results or were lost to follow-up, and those who continued saw minimal to moderate improvement.

Monitoring new epilepsy drugs after they're sold is crucial to find rare and long-term side effects that initial tests might miss.

Photobiomodulation therapy significantly increases hair density and growth for androgenic alopecia, but more research is needed to confirm safety.

The PCOS-specific questionnaire needs more work to fully measure quality of life in clinical trials.

Low-level laser therapy significantly increases hair density in adults with hair loss, with low-frequency treatment being more effective.

The anti-viral drug Elvitegravir may protect brain cells from damage related to neurodegenerative diseases.

The Scalp Coverage Scoring method reliably measures hair density from images.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Finasteride has various adverse effects, including sexual dysfunction and mental health issues, which vary by age and gender.

No current patient-reported outcome measure fully meets FDA requirements for alopecia treatments.

FDA-cleared devices may help treat hair loss, but more research needed; consult dermatologist before use.

Skin diseases are common and can significantly affect people's lives; better outcome measures and ethical clinical trials are needed to improve dermatology care.

Some medications can help increase sexual desire and function in women.

Lasers are FDA-approved for permanent hair reduction, not removal, and more research is needed to improve treatments.

Low-level light therapy is FDA-approved for male pattern hair loss, increases hair count and strength, and is considered safe for use.

The document concluded that FDA-approved treatments like minoxidil and finasteride are effective for hair loss, while the effectiveness of natural remedies and other non-approved treatments is not well-supported by evidence.

Scalp cooling effectively reduces hair loss from chemotherapy.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

The review concluded that better studies are needed to prove if Low-Level Laser Therapy devices for hair growth really work.

Minoxidil and finasteride are the main FDA-approved treatments for hair loss, with other methods showing promise but lacking strong evidence.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Various treatments, including FDA-approved drugs, natural products, and oral supplements, can help with hair loss, but a patient's medical history and potential allergies should be considered when choosing a treatment.

Stem cell therapies show promise for hair regrowth in androgenetic alopecia.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

The conclusion is that differentiating wound types in RDEB patients is important for clinical trials and understanding the disease.

Microneedling combined with other treatments significantly improves hair growth in people with hair loss and is safe.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.